JPWO2021022008A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021022008A5
JPWO2021022008A5 JP2022506419A JP2022506419A JPWO2021022008A5 JP WO2021022008 A5 JPWO2021022008 A5 JP WO2021022008A5 JP 2022506419 A JP2022506419 A JP 2022506419A JP 2022506419 A JP2022506419 A JP 2022506419A JP WO2021022008 A5 JPWO2021022008 A5 JP WO2021022008A5
Authority
JP
Japan
Prior art keywords
drawings
present application
invention described
application
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022506419A
Other languages
Japanese (ja)
Other versions
JP2022543046A (en
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/044196 external-priority patent/WO2021022008A1/en
Publication of JP2022543046A publication Critical patent/JP2022543046A/en
Publication of JPWO2021022008A5 publication Critical patent/JPWO2021022008A5/ja
Pending legal-status Critical Current

Links

Claims (1)

本願明細書または図面に記載された発明。An invention described in the specification or drawings of the present application.
JP2022506419A 2019-07-30 2020-07-30 virus-like particle vaccine Pending JP2022543046A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962880547P 2019-07-30 2019-07-30
US62/880,547 2019-07-30
US202062990318P 2020-03-16 2020-03-16
US62/990,318 2020-03-16
PCT/US2020/044196 WO2021022008A1 (en) 2019-07-30 2020-07-30 Virus-like particle vaccines

Publications (2)

Publication Number Publication Date
JP2022543046A JP2022543046A (en) 2022-10-07
JPWO2021022008A5 true JPWO2021022008A5 (en) 2023-08-07

Family

ID=74228282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506419A Pending JP2022543046A (en) 2019-07-30 2020-07-30 virus-like particle vaccine

Country Status (7)

Country Link
US (2) US20220280633A1 (en)
EP (1) EP4004036A4 (en)
JP (1) JP2022543046A (en)
CN (1) CN114729030A (en)
AU (1) AU2020321021A1 (en)
CA (1) CA3149390A1 (en)
WO (1) WO2021022008A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3114699A1 (en) 2018-10-09 2020-04-16 The University Of British Columbia Compositions and systems comprising transfection-competent vesicles free of organic-solvents and detergents and methods related thereto
WO2022008973A2 (en) * 2020-07-10 2022-01-13 Covid Diagnostics Ltd. Compositions, methods, and systems for detecting immune response
CN112760420B (en) * 2021-02-05 2023-05-26 中国科学院长春应用化学研究所 Primer, probe and kit for detecting novel coronavirus SARS-CoV-2
CN114957409A (en) * 2021-02-26 2022-08-30 中国科学院上海巴斯德研究所 Method and product for coronavirus intervention based on S protein R815 locus
WO2022191742A1 (en) * 2021-03-11 2022-09-15 Dukhovlinov Ilya Vladimirovich A method for assessment of the cellular immune
CA3218711A1 (en) * 2021-05-13 2022-11-17 Roee Amit Methods and compositions for treatment of viral infection
WO2022261355A1 (en) * 2021-06-09 2022-12-15 Chimeron Bio Corporation Self-amplifying rna-based vlp vaccines
WO2023023597A1 (en) * 2021-08-18 2023-02-23 Nanored Llc Virus-like particle
IL310010A (en) * 2021-09-09 2024-03-01 Universit?T Basel Biologically produced nucleic acid for vaccine production
WO2023062651A1 (en) * 2021-10-13 2023-04-20 Padmanabh Patil Harshad Virus-like particles for respiratory syncytial virus and method of preparation thereof
RU2769224C1 (en) * 2021-12-30 2022-03-29 федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации Recombinant virus-like particles for induction of specific immunity against severe acute respiratory syndrome virus sars-cov-2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE489969T1 (en) * 2002-06-20 2010-12-15 Cytos Biotechnology Ag PACKAGED VIRUS-LIKE PARTICLES IN COMBINATION WITH CPG FOR USE AS ADJUVANTS WITH ALLERGENS. MANUFACTURING PROCESS AND USE
US20100015218A1 (en) * 2007-02-16 2010-01-21 Vasant Jadhav Compositions and methods for potentiated activity of biologically active molecules
WO2011002522A2 (en) * 2009-07-02 2011-01-06 Medimmune, Llc Methods of making and using synthetic viruses
CN103154251A (en) * 2010-09-30 2013-06-12 佛兰瓦克斯有限责任公司 Generation of virosome particles
PL2811981T3 (en) * 2012-02-07 2019-09-30 Infectious Disease Research Institute Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
US10829543B2 (en) * 2012-10-29 2020-11-10 The University Of North Carolina At Chapel Hill Compositions and methods for inhibiting pathogen infection
WO2016039620A2 (en) * 2014-09-12 2016-03-17 Bestewil Holding B.V. Respiratory syncytial virus virosomes
US10676511B2 (en) * 2015-09-17 2020-06-09 Ramot At Tel-Aviv University Ltd. Coronaviruses epitope-based vaccines

Similar Documents

Publication Publication Date Title
JP2023115329A5 (en)
JP2022184985A5 (en)
JP2021184963A5 (en)
JP2022068302A5 (en)
JP2024036694A5 (en)
JPWO2021188969A5 (en)
JP2020010717A5 (en)
JP2019142968A5 (en)
JP2023022224A5 (en)
JP2022191211A5 (en)
JP2023181322A5 (en)
JP2023166402A5 (en)
JPWO2021213924A5 (en)
JP2022024034A5 (en)
JPWO2021194942A5 (en)
JP2022185040A5 (en)
JP2022122972A5 (en)
JP2024012435A5 (en)
JP2020079331A5 (en)
JP2021008510A5 (en)
JP2023085551A5 (en)
JP2022060220A5 (en)
JP2022064180A5 (en)
JP2023078173A5 (en)
JP2023145479A5 (en)